Related Experiment Videos
Phototoxic blisters from high frusemide dosage.
The British Journal of Dermatology
|May 1, 1976
Summary
High doses of frusemide can cause phototoxic blistering in patients with chronic renal failure. This drug-induced skin reaction resembles other phototoxic conditions, highlighting a potential side effect of this diuretic treatment.
Area of Science:
- Dermatology
- Nephrology
- Pharmacology
Background:
- Chronic renal failure (CRF) management often involves potent diuretics like frusemide.
- High-dose frusemide therapy is prescribed to manage fluid overload in CRF patients.
Observation:
- Patients undergoing high-dose frusemide treatment for CRF have developed blistering on sun-exposed skin.
- The observed blistering shares clinical and etiological similarities with nalidixic acid phototoxicity and porphyria cutanea tarda.
Findings:
- The blistering is characterized as a phototoxic reaction, indicating sensitivity to light.
- Frusemide, at high therapeutic concentrations, may induce photosensitivity in susceptible individuals.
Implications:
- Clinicians should be aware of the potential for phototoxic blistering in CRF patients on high-dose frusemide.
- Photoprotective measures may be necessary for these patients to prevent or mitigate skin reactions.
- Further research into the mechanisms of frusemide-induced phototoxicity is warranted.